Asprosin in early detection of nephropathy in type2 diabetes mellitus
Background: Diabetic nephropathy (DN) accounts for the most prevalent cause of chronic kidney disease and end-stage renal disease (ESRD) globally, accounting for about 50% of all ESRD patients that need management with dialysis or a renal transplant. Objectives: The aim of this study was to the role...
Main Authors: | Ola Hussein Abed Alwahid, Talat Tariq Khalil, Mohamed Abed AL-Ridha Ismael |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Medical Journal of Babylon |
Subjects: | |
Online Access: | http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2023;volume=20;issue=4;spage=689;epage=696;aulast=Abed |
Similar Items
-
Concentration of Asprosin Associated with Poor Control of Type 2 Diabetes Mellitus in Diyala Province
by: Alaa Abed Mahmoud, et al.
Published: (2023-06-01) -
Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes
by: Deng X, et al.
Published: (2020-11-01) -
Association Between Serum Asprosin and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus in the Community: A Cross-Sectional Study
by: Xu L, et al.
Published: (2022-06-01) -
Relationship of asprosin and diabetes: a meta-analysis
by: Xiandong Zeng, et al.
Published: (2025-01-01) -
ASPROSIN: A NOVEL BIOMARKER OF TYPE 2 DIABETES MELLITUS
by: Asmaa Elnagar, et al.
Published: (2018-11-01)